These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Current status of chemically synthesized inhibitors of Ebola virus. Cardile AP; Mayers DL; Bavari S Recent Pat Antiinfect Drug Discov; 2014; 9(2):97-103. PubMed ID: 25808170 [TBL] [Abstract][Full Text] [Related]
7. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection. Wu W; Liu S Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081 [TBL] [Abstract][Full Text] [Related]
8. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus. Dhama K; Karthik K; Khandia R; Chakraborty S; Munjal A; Latheef SK; Kumar D; Ramakrishnan MA; Malik YS; Singh R; Malik SVS; Singh RK; Chaicumpa W Front Immunol; 2018; 9():1803. PubMed ID: 30147687 [TBL] [Abstract][Full Text] [Related]
9. Novel Small Molecule Entry Inhibitors of Ebola Virus. Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510 [TBL] [Abstract][Full Text] [Related]
10. Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro. Gong M; Yang Y; Huang Y; Gan T; Wu Y; Gao H; Li Q; Nie J; Huang W; Wang Y; Zhang R; Zhong J; Deng F; Rao Y; Ding Q Antiviral Res; 2021 Oct; 194():105161. PubMed ID: 34391783 [TBL] [Abstract][Full Text] [Related]